(Q30481519)

14 August 2017

The calm after the cytokine storm: lessons from the TGN1412 trial (English)

1 reference

14 August 2017

1 reference

1

E William St Clair

1 reference

PMC publication ID

2269728

14 August 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

Journal of Clinical Investigation

14 August 2017

1 reference

14 August 2017

118

1 reference

14 August 2017

4

1 reference

14 August 2017

1344-1347

1 reference

A CD28 superagonistic antibody elicits 2 functionally distinct waves of T cell activation in rats

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2269728

Manipulation of regulatory T-cell number and function with CD28-specific monoclonal antibodies

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2269728

The Northwick Park tragedy--protecting healthy volunteers in future first-in-man trials

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2269728

Establishing risk of human experimentation with drugs: lessons from TGN1412.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2269728

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2269728

Loss of Siglec expression on T lymphocytes during human evolution

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2269728

Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2269728

Effective treatment of adjuvant arthritis with a stimulatory CD28-specific monoclonal antibody.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2269728

Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in "human immune system" Rag2(-/-)gammac(-/-) mice

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18357347

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18357347

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

"Cytokine storm" in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeutics

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18357347

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1172/JCI35382

1 reference

14 August 2017

1 reference

PMC publication ID

2269728

14 August 2017

PubMed publication ID

18357347

1 reference

PMC publication ID

2269728